VTR · Ventas, Inc.
$97.92
+2.45% last session
End-of-day data · updated 2026-07-25
Market cap
$49B
Enterprise value
$62B
Trailing P/E
182.8
Forward P/E
118.7
Dividend yield
2.0%
Beta
0.72
Avg volume
4M
Employees
1K
2D change
2.67%
5D change
4.45%
10D change
8.93%
30D change
15.66%
60D change
14.43%
MTD change
12.14%
YTD change
31.52%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — VTR
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-22
Latest call per bank · past 12 months
Barclays
Equal-Weight$99.00
+1.1% vs priceWells Fargo
Overweight$96.00
-2.0% vs priceJefferies
Buy$100
+2.1% vs priceJP Morgan
Overweight$94.00
-4.0% vs priceUBS
Neutral$93.00
-5.0% vs priceRBC Capital
Outperform$98.00
+0.1% vs priceCitigroup
Buy$100
+2.1% vs priceMorgan Stanley
Equal-Weight$75.00
-23.4% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-22 | Mizuho | Maintains | Outperform | $98.00 → $104 |
| 2026-07-07 | Barclays | Initiates | Overweight → Equal-Weight | $0.00 → $99.00 |
| 2026-07-01 | Evercore ISI Group | Maintains | Outperform | $95.00 → $96.00 |
| 2026-06-18 | Scotiabank | Maintains | Sector Perform | $95.00 → $88.00 |
| 2026-06-01 | Wells Fargo | Maintains | Overweight | $93.00 → $96.00 |
| 2026-05-21 | Scotiabank | Maintains | Sector Perform | $93.00 → $95.00 |
| 2026-05-13 | Jefferies | Maintains | Buy | $97.00 → $100 |
| 2026-05-11 | JP Morgan | Maintains | Overweight | $93.00 → $94.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-27
- RSI (14): RSI is 77 — overbought territory; the recent run-up may be due for a pause.
- Price vs 50-day MA: Trading 14.1% above the 50-day MA ($87.96).
- Price vs 200-day MA: Trading 23.4% above the 200-day MA ($81.27).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is positive (+0.53) — short-term momentum is improving.
- 52-week range: Price is within 5% of the 52-week high ($100.32).
VTR Price Chart
Loading chart for VTR…
Fundamentals
About Ventas, Inc.
Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With more than 1,400 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its approximately 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. was incorporated in 1983 and is based in Chicago, United States. The firm was incorporated in Delaware.
More in REIT - Healthcare Facilities
WELL
Welltower Inc.
$178B 36.8% YTD
OHI
Omega Healthcare Investors, Inc
$16B 20.1% YTD
DOC
Healthpeak Properties, Inc.
$15B 44.0% YTD
AHR
American Healthcare REIT, Inc.
$11B 23.3% YTD
CTRE
CareTrust REIT, Inc.
$10B 22.1% YTD
HR
Healthcare Realty Trust Incorpo
$8B 29.4% YTD
SBRA
Sabra Health Care REIT, Inc.
$6B 21.6% YTD
NHI
National Health Investors, Inc.
$4B 7.9% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.